Office of Research & Development |
  |
Talk to the Veterans Crisis Line now
An official website of the United States government
Project Number: | I01RX002615-01 |
| Title: | Dopamine treatments for diabetic retinopathy |
| Principal Investigator: | Machelle T. Pardue |
| Location: | Decatur, GA |
| Congressional District Code: | 4 |
| Research Service: | Rehabilitation R&D |
| Project Period: | January 2018 - December 2021 |
| FY 2021 Funding Amount: | $294,434 |
| Total Award Amount (all years): |
$1,029,338 |
| Abstract: |
View full abstract and other project information on NIH RePORTER Go To NIH RePORTER Excerpt: Diabetic retinopathy (DR) is already the leading cause of blindness in working age adults, and the incidence of DR is predicted to double in the US by 2050 (NIH National Eye Institute data). With the prevalence of diabetes in veterans significantly higher than the civilian population, it is imperative that we develop new and more effective treatments for vision loss caused by DR. In the last funding cycle, we identified a novel neuroprotective agent for early stage DR: dopamine. Our research con... |